Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Kelun Pharma Buys Qingfa Pharma

publication date: Dec 28, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Sichuan Kelun Pharma will purchase Guangdong Qingfa Pharmaceutical for a total of 148 million RMB ($22.3 million). The price consists of 24 million RMB ($3.6 million) for the company and 124 million RMB ($18.7 million) for repayment of debt. This is small change for Kelun Pharma, which raised $750 million in its IPO on the Shenzhen exchange in May of this year. More details....

Stock Symbol: (SZEX: 002422)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...